+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of histopathological criteria for identifying node-negative breast cancer with high risk of early recurrence in the NSAS-BC protocol study



Evaluation of histopathological criteria for identifying node-negative breast cancer with high risk of early recurrence in the NSAS-BC protocol study



Breast Cancer 7(3): 201-209



The histopathological criteria for high-risk node-negative primary breast cancer stated in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol were used to grade a consecutive series of 488 cases at our hospital. To validate the criteria retrospectively, we examined the histological features of node-negative primary breast cancers which showed early relapse within 2 years after surgical therapy. Early relapse occurred in 12 patients, distant metastases in 11, and local recurrence in one. Among 278 cases followed for up to 1.5 years or longer, early systemic relapse was detected in 10 (5.8%) of 172 higher-grade tumors (9 invasive ductal carcinomas of nuclear grade 3 and one invasive ductal carcinoma of nuclear grade 2) and one stromal cell sarcoma. Among the 115 low-risk tumors, only one case (0.9%) of invasive ductal carcinomas with nuclear grade 1 showed early local recurrence. Early relapse occurred in only one (1.5%) of 67 tumors with an invasive component of 1.0 cm but in 11 (5.2%) of 211 tumors with an invasive component of 1.1 cm. The recurrence rate increased to 9.3% (8/86) when tumor invasion was 2.1 cm. In 12 cancers showing recurrence, strand structure, large central acellular zones, and squamoid features were histologically observed in four, two, and three cases, respectively. The present results confirmed the reported tendency of correlation between strand pattern and bone metastasis, large central acellular zones and lung and brain metastasis, and squamoid features and lung metastasis. Synchronous bilateral and unilateral multiple cancers were characterized by lower nuclear grades. At our hospital, the criteria used in the NSAS-BC protocol were demonstrated to identify node-negative cancers with high risk of early recurrence at a hospital level. To further identify groups prone to recurrence, longer follow-up would be necessary. In addition, the histological criteria could be improved to correlate with patient outcome more accurately.

(PDF emailed within 1 workday: $29.90)

Accession: 046010351

Download citation: RISBibTeXText

PMID: 11029799


Related references

Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol. Japanese Journal of Clinical Oncology 29(9): 413-420, 1999

Rapid growth rate: a method of identifying node-negative breast cancer patients with a high risk of recurrence. Journal of Chronic Diseases 36(12): 847-853, 1983

High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. Journal of Clinical Oncology 18(5): 1075-1083, 2000

Possible histopathological criteria for the evaluation of prognosis in lymph node negative breast cancer patients. Archives of Gynecology 237(SUPPL): 313, 1985

Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Diseases of the Colon and Rectum 44(11): 1682-1688, 2001

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. Journal of Clinical Oncology 28(11): 1829-1834, 2010

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer. Breast 21(5): 621-628, 2013

Node negative breast cancer identifying the high risk patient. Breast Cancer Research & Treatment 19(2): 178, 1991

Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer. Clinical Cancer Research 22(20): 5043-5048, 2016

Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis. Journal of Cancer Research and Clinical Oncology 139(5): 853-860, 2013

Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer. Medicine 97(51): E13435-E13435, 2018

Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?. Cancer 123(14): 2626-2633, 2017

Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. International Journal of Radiation Oncology, Biology, Physics 62(1): 175-182, 2005

High risk profile for recurrence and survival of 1647 node negative breast cancer patients. Proceedings American Society of Clinical Oncology Annual Meeting 5: 65, 1986

Evaluation of the Interobserver Agreement in the Number of Mitotic Figures Breast Carcinoma as Simulation of Quality Monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Protocol. Cancer Science 91(4): 451-457, 2000